-$176M
Net insider buying / selling at Vertex Pharmaceuticals (VRTX) over the last 2 years. Updated Jul 7, 2026
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Vertex Pharmaceuticals Insiders Buying or Selling?
Vertex Pharmaceuticals (VRTX) has had no reported insider transactions in the past 90 days. The most recent was Ourania Tatsis, who sold 1,500 shares at $524.99 on July 2, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the VRTX AI Score. For government officials trading this stock, see VRTX congressional trading.
Who’s Trading Vertex Pharmaceuticals Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| JEFFREY LEIDEN | Sold $61M | 17 | Dec 3, 2025 |
| Reshma Kewalramani | Sold $28M | 16 | Feb 27, 2026 |
| Amit Sachdev | Sold $28M | 9 | Feb 25, 2026 |
| WAGNER CHARLES F JR | Sold $11M | 4 | Jan 6, 2026 |
| Ourania Tatsis | Sold $11M | 14 | Jul 2, 2026 |
| Carmen Bozic | Sold $9.2M | 8 | Jun 18, 2026 |
Recent Vertex Pharmaceuticals Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Ourania Tatsis | Jul 2, 2026 | Sell | 1,500 | $524.99 | $790,000 |
| Duncan McKechnie | Jul 2, 2026 | Sell | 1,541 | $519 | $800,000 |
| Joy Liu | Jul 1, 2026 | Sell | 828 | $502.71 | $420,000 |
| Carmen Bozic | Jun 18, 2026 | Sell | 1,020 | $462.17 | $470,000 |
| Carmen Bozic | Jun 5, 2026 | Sell | 1,745 | $450 | $790,000 |
| Joy Liu | Jun 1, 2026 | Sell | 828 | $439.91 | $360,000 |
| Carmen Bozic | May 29, 2026 | Sell | 1,974 | $450 | $890,000 |
| Carmen Bozic | May 15, 2026 | Sell | 1,354 | $453.45 | $610,000 |
| Mark Bunnage | May 15, 2026 | Sell | 33 | $453.45 | $15,000 |
| Carmen Bozic | May 12, 2026 | Sell | 6,988 | $450 | $3.1M |
| Sangeeta Bhatia | May 4, 2026 | Sell | 318 | $423.73 | $130,000 |
| Joy Liu | May 1, 2026 | Sell | 1,104 | $425.02 | $470,000 |
| Joy Liu | Apr 1, 2026 | Sell | 978 | $449.17 | $440,000 |
| Carmen Bozic | Mar 27, 2026 | Sell | 2,329 | $450.95 | $1.1M |
| Carmen Bozic | Mar 13, 2026 | Sell | 2,329 | $481.79 | $1.1M |
| Duncan McKechnie | Mar 11, 2026 | Sell | 2,633 | $498.42 | $1.3M |
| Duncan McKechnie | Mar 4, 2026 | Sell | 2,437 | $475.3 | $1.2M |
| Joy Liu | Mar 2, 2026 | Sell | 892 | $495.96 | $440,000 |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 15,580 | $495.38 | $7.7M |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 5,995 | $496.16 | $3M |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 3,498 | $494.33 | $1.7M |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 3,278 | $488.27 | $1.6M |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 2,725 | $490.54 | $1.3M |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 2,520 | $493.29 | $1.2M |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 2,510 | $487.13 | $1.2M |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 1,725 | $496.95 | $860,000 |
| Carmen Bozic | Feb 27, 2026 | Sell | 2,329 | $480.31 | $1.1M |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 949 | $491.3 | $470,000 |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 460 | $489.32 | $230,000 |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 400 | $479.75 | $190,000 |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 240 | $482.84 | $120,000 |
| Reshma Kewalramani | Feb 27, 2026 | Sell | 120 | $481.5 | $58,000 |
| Kristen Ambrose | Feb 26, 2026 | Sell | 357 | $483.36 | $170,000 |
| Amit Sachdev | Feb 25, 2026 | Sell | 1,846 | $486.35 | $900,000 |
| Duncan McKechnie | Feb 25, 2026 | Sell | 2,500 | $486.35 | $1.2M |
| Duncan McKechnie | Feb 25, 2026 | Sell | 2,410 | $489 | $1.2M |
| Ourania Tatsis | Feb 25, 2026 | Sell | 260 | $486.35 | $130,000 |
| Mark Bunnage | Feb 25, 2026 | Sell | 620 | $486.35 | $300,000 |
| Jonathan Biller | Feb 25, 2026 | Sell | 945 | $486.35 | $460,000 |
| Atkinson Edward Morrow III | Feb 25, 2026 | Sell | 668 | $486.35 | $320,000 |
| Kristen Ambrose | Feb 25, 2026 | Sell | 223 | $486.35 | $110,000 |
| Amit Sachdev | Feb 19, 2026 | Sell | 19,662 | $468.57 | $9.2M |
| Amit Sachdev | Feb 19, 2026 | Sell | 11,712 | $470.54 | $5.5M |
| Amit Sachdev | Feb 19, 2026 | Sell | 10,263 | $467.75 | $4.8M |
| Amit Sachdev | Feb 19, 2026 | Sell | 7,241 | $469.61 | $3.4M |
| Amit Sachdev | Feb 19, 2026 | Sell | 4,237 | $471.43 | $2M |
| Amit Sachdev | Feb 19, 2026 | Sell | 2,730 | $465.05 | $1.3M |
| Amit Sachdev | Feb 19, 2026 | Sell | 1,848 | $465.8 | $860,000 |
| Amit Sachdev | Feb 19, 2026 | Sell | 920 | $463.91 | $430,000 |
| Mark Bunnage | Feb 18, 2026 | Sell | 1,182 | $473.68 | $560,000 |
| Jonathan Biller | Feb 18, 2026 | Sell | 1,244 | $473.68 | $590,000 |
| Ourania Tatsis | Feb 18, 2026 | Sell | 368 | $473.68 | $170,000 |
| Atkinson Edward Morrow III | Feb 18, 2026 | Sell | 817 | $473.68 | $390,000 |
| Kristen Ambrose | Feb 18, 2026 | Sell | 638 | $473.68 | $300,000 |
| Mark Bunnage | Feb 17, 2026 | Sell | 2,437 | $489.46 | $1.2M |
| Jonathan Biller | Feb 17, 2026 | Sell | 2,476 | $489.46 | $1.2M |
| Atkinson Edward Morrow III | Feb 17, 2026 | Sell | 2,031 | $489.46 | $990,000 |
| Kristen Ambrose | Feb 17, 2026 | Sell | 1,557 | $489.46 | $760,000 |
| Ourania Tatsis | Feb 17, 2026 | Sell | 609 | $489.46 | $300,000 |
| Ourania Tatsis | Feb 13, 2026 | Sell | 1,500 | $499.99 | $750,000 |
| Jonathan Biller | Feb 13, 2026 | Sell | 988 | $499 | $490,000 |
| Sangeeta Bhatia | Feb 13, 2026 | Sell | 266 | $500 | $130,000 |
| Mark Bunnage | Feb 11, 2026 | Sell | 2,021 | $460.43 | $930,000 |
| Jonathan Biller | Feb 11, 2026 | Sell | 1,925 | $460.43 | $890,000 |
| Atkinson Edward Morrow III | Feb 11, 2026 | Sell | 1,751 | $460.43 | $810,000 |
| Kristen Ambrose | Feb 11, 2026 | Sell | 1,376 | $460.43 | $630,000 |
| Ourania Tatsis | Feb 11, 2026 | Sell | 466 | $460.43 | $210,000 |
| Ourania Tatsis | Jan 7, 2026 | Sell | 4,500 | $474.99 | $2.1M |
| WAGNER CHARLES F JR | Jan 6, 2026 | Sell | 9,532 | $461 | $4.4M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 15,681 | $452.2 | $7.1M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 10,360 | $453.34 | $4.7M |
| WAGNER CHARLES F JR | Dec 3, 2025 | Sell | 7,000 | $461 | $3.2M |
| Ourania Tatsis | Dec 3, 2025 | Sell | 4,500 | $449.99 | $2M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 7,899 | $445.56 | $3.5M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 5,880 | $449.84 | $2.6M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 5,809 | $451.2 | $2.6M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 4,469 | $440.4 | $2M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 4,352 | $444.36 | $1.9M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 2,469 | $443.21 | $1.1M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 2,320 | $448.78 | $1M |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 2,070 | $455.22 | $940,000 |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 1,320 | $441.26 | $580,000 |
| JEFFREY LEIDEN | Dec 3, 2025 | Sell | 1,152 | $447.05 | $520,000 |
| Jonathan Biller | Dec 3, 2025 | Sell | 347 | $449 | $160,000 |
| Atkinson Edward Morrow III | Nov 17, 2025 | Sell | 2,500 | $434.58 | $1.1M |
| JEFFREY LEIDEN | Nov 14, 2025 | Sell | 32,234 | $440.3 | $14M |
| JEFFREY LEIDEN | Nov 14, 2025 | Sell | 21,330 | $441.35 | $9.4M |
| JEFFREY LEIDEN | Nov 14, 2025 | Sell | 40 | $442 | $18,000 |
| JEFFREY LEIDEN | Nov 13, 2025 | Sell | 18,528 | $440.22 | $8.2M |
| JEFFREY LEIDEN | Nov 13, 2025 | Sell | 1,160 | $441.05 | $510,000 |
| Jonathan Biller | Oct 2, 2025 | Sell | 694 | $404.21 | $280,000 |
| Sangeeta Bhatia | Aug 27, 2025 | Sell | 266 | $386.69 | $100,000 |
| Reshma Kewalramani | Aug 6, 2025 | Buy | 5,710 | $389.95 | $2.2M |
| Reshma Kewalramani | Aug 6, 2025 | Buy | 4,290 | $389.08 | $1.7M |
| BRUCE SACHS | Aug 6, 2025 | Buy | 3,366 | $389.84 | $1.3M |
| BRUCE SACHS | Aug 6, 2025 | Buy | 1,634 | $389.36 | $640,000 |
| DAVID ALTSHULER | May 15, 2025 | Sell | 52 | $424.69 | $22,000 |
| Sangeeta Bhatia | May 2, 2025 | Sell | 400 | $505.86 | $200,000 |
| DAVID ALTSHULER | Mar 13, 2025 | Sell | 3,231 | $510 | $1.6M |
| WAGNER CHARLES F JR | Mar 10, 2025 | Sell | 3,298 | $500 | $1.6M |
| Ourania Tatsis | Mar 10, 2025 | Sell | 3,242 | $499.99 | $1.6M |
| DAVID ALTSHULER | Mar 10, 2025 | Sell | 3,231 | $500 | $1.6M |
| Ourania Tatsis | Mar 4, 2025 | Sell | 4,058 | $485.49 | $2M |
| DAVID ALTSHULER | Mar 3, 2025 | Sell | 3,231 | $490 | $1.6M |
| Atkinson Edward Morrow III | Feb 27, 2025 | Sell | 2,650 | $475.34 | $1.3M |
| DAVID ALTSHULER | Feb 27, 2025 | Sell | 1,272 | $480 | $610,000 |
| Ourania Tatsis | Feb 27, 2025 | Sell | 530 | $475.34 | $250,000 |
| Atkinson Edward Morrow III | Feb 25, 2025 | Sell | 1,767 | $480.95 | $850,000 |
| Ourania Tatsis | Feb 25, 2025 | Sell | 354 | $480.95 | $170,000 |
| Kristen Ambrose | Feb 25, 2025 | Sell | 884 | $480.95 | $430,000 |
| DAVID ALTSHULER | Feb 25, 2025 | Sell | 848 | $480.95 | $410,000 |
| DAVID ALTSHULER | Feb 20, 2025 | Sell | 1,111 | $480 | $530,000 |
| Jonathan Biller | Feb 18, 2025 | Sell | 1,657 | $455.06 | $750,000 |
| Ourania Tatsis | Feb 18, 2025 | Sell | 244 | $455.06 | $110,000 |
| Kristen Ambrose | Feb 18, 2025 | Sell | 671 | $455.06 | $310,000 |
| Jonathan Biller | Feb 11, 2025 | Sell | 3,433 | $459.87 | $1.6M |
| Atkinson Edward Morrow III | Feb 11, 2025 | Sell | 1,747 | $459.83 | $800,000 |
| Kristen Ambrose | Feb 11, 2025 | Sell | 1,376 | $459.83 | $630,000 |
| Ourania Tatsis | Feb 11, 2025 | Sell | 310 | $459.83 | $140,000 |
| DAVID ALTSHULER | Nov 15, 2024 | Sell | 15 | $478.56 | $7,200 |
| WAGNER CHARLES F JR | Nov 11, 2024 | Sell | 3,000 | $518.27 | $1.6M |
| Reshma Kewalramani | Nov 8, 2024 | Sell | 15,198 | $515 | $7.8M |
Frequently Asked Questions: Vertex Pharmaceuticals Insider Trading
Vertex Pharmaceuticals insiders have not reported any transactions in the past 90 days.
The most recent sale was by Ourania Tatsis who sold 1,500 shares on July 2, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Kewalramani Reshma has bought the most VRTX stock in the last 2 years, with a total value of $3.9M.
LEIDEN JEFFREY M has sold the most VRTX stock in the last 2 years, with a total value of $61M.
The total value of insider transactions for Vertex Pharmaceuticals in the last 2 years is negative, amounting to -$176M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
